Rx Roundup: Quiz of the Week — May 10, 2024

Quiz
Article

Test your pharmacy news knowledge with our weekly quiz.

Did you get your fill of pharmacy news this week? Take the Rx Roundup quiz of the week and test your knowledge about the latest stories published by the Drug Topics team from May 6 to May 10.

The SOLARIS clinical trial evaluated TEV-749, a once-monthly, subcutaneous, long-acting injectable form of what antipsychotic medication?


Recent Videos
Related Content
FDA Accepts BLA Resubmission for Epidermolysis Bullosa Gene Therapy

FDA Accepts BLA Resubmission for Epidermolysis Bullosa Gene Therapy

Killian Meara
November 12th 2024
Article

The agency assigned prademagene zamikeracel a PDUFA target action date of April 29, 2025.

Lumateperone Demonstrates Efficacy in Reducing Symptomatic Relapse Risk in Schizophrenia

Lumateperone Demonstrates Efficacy in Reducing Symptomatic Relapse Risk in Schizophrenia

Lauren Biscaldi, MS, Managing Editor
November 5th 2024
Article

The drug is also approved to treat schizophrenia and bipolar depression.

FDA Approves Journey Medical’s Emrosi for Rosacea

FDA Approves Journey Medical’s Emrosi for Rosacea

Lauren Massaro
November 5th 2024
Article

“Emrosi has potential to become the best-in-class oral medication to treat the condition,” said the CEO of Journey Medical.

FDA Expands OA REMS, Mandates Mail-Back Envelopes for Opioid Analgesics

FDA Expands OA REMS, Mandates Mail-Back Envelopes for Opioid Analgesics

Lauren Massaro
November 4th 2024
Article

The FDA has mandated that companies participating in the Opioid Analgesic Risk Evaluation and Mitigation Strategy program provide pre-paid mail-back envelopes for unused or expired opioid medications.

Risk of Parkinson Disease Increases With Gastrointestinal Mucosal Damage

Risk of Parkinson Disease Increases With Gastrointestinal Mucosal Damage

Brian Nowosielski
October 30th 2024
Article

Researchers addressed the gut-first hypothesis of Parkinson disease by identifying how mucosal damage impacts risk of development.

Pharmacy Screening Can Identify Depression in Older Adults

Pharmacy Screening Can Identify Depression in Older Adults

Hannah Dellabella
October 21st 2024
Article

Normalizing conversations around mental health in older adult populations can improve outcomes.

© 2024 MJH Life Sciences

All rights reserved.